Hipra Scientific, S.l.u
Clinical trials sponsored by Hipra Scientific, S.l.u, explained in plain language.
-
New booster shot shows promise for protecting vulnerable patients against COVID-19
⭐️ VACCINE ⭐️ CompletedThis study tested an extra dose of the PHH-1V COVID-19 vaccine in 241 adults with weakened immune systems (due to HIV, kidney disease, or autoimmune conditions) who had already received other COVID-19 vaccines. The goal was to see if the booster increased their antibody levels ag…
Phase: PHASE2, PHASE3 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 03:41 UTC
-
New COVID booster shows promise in trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new booster vaccine (PHH-1V81) against COVID-19 in 913 adults who had already received mRNA vaccines. The goal was to see if it is safe and boosts the immune system against newer virus variants. Participants received either the new vaccine or an existing one, …
Phase: PHASE2, PHASE3 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 03:41 UTC
-
New COVID booster for teens shows promise in trial
⭐️ VACCINE ⭐️ CompletedThis study tested a booster shot called BIMERVAX in 242 teens aged 12 to 17 who had already received a different COVID-19 vaccine. The goal was to see if it was safe and boosted their immune system against the virus. Researchers measured antibody levels and tracked any side effec…
Phase: PHASE2 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 03:41 UTC
-
New booster shot tested as potential COVID-19 defense
⭐️ VACCINE ⭐️ CompletedThis study tested a new COVID-19 booster vaccine called PHH-1V. Researchers compared it to the Pfizer booster shot in adults who were already fully vaccinated. The goal was to see if the new vaccine was as safe and effective at triggering an immune response, including against new…
Phase: PHASE2 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:18 UTC